Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FTXH vs. PRHSX: which is better?

Bottom line

FTXH vs PRHSX: the short answer

FTXH (First Trust Nasdaq Pharmaceuticals ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both etfs.

But PRHSX is far broader, holding 279 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.

FTXH is cheaper at 0.6% vs 0.83% — a difference of $23 a year per $10,000 invested.

Over five years, FTXH returned +6.5% a year vs +4.2% for PRHSX.

Updated Nov 19, 2026

FTXH vs PRHSX side by side

FTXHPRHSX
TypeETFMutual fund
Fund familyFirst TrustT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.6%0.83%
Annual cost per $10k$60$83
10-yr cost on $10k (prospectus)—$1,025
Max front loadNone—
12b-1 fee0%—
1-yr return+24.0%+17.7%
5-yr return (annualized)+6.5%+4.2%
10-yr return (annualized)—+9.1%
Best quarter+18.3%+23.5%
Worst quarter−17.4%−15.8%
Net assets (fund)$36.2M$11.9B
Number of holdings51279
Portfolio turnover35%62%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFTXHPRHSXDifference
2025+24.0%+17.7%+6.3%
2024+3.0%+1.8%+1.1%
2023−1.4%+3.1%−4.5%
2022+2.5%−12.2%+14.7%
2021+6.1%+13.3%−7.2%
2020+10.9%+30.1%−19.3%
2019+22.4%+29.1%−6.8%
2018−8.4%+1.2%−9.6%
2017+18.8%+28.0%−9.2%

Source: Fund prospectus bar charts

Holdings overlap

9 of FTXH's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingFTXHPRHSX
Eli Lilly & Company7.77%14.28%
Abbvie Inc7.39%5.10%
Merck & Company Inc7.07%4.01%
Johnson & Johnson6.96%6.63%
Bristol-myers Squibb Company6.29%2.11%
Cardinal Health Inc3.53%1.03%
Vertex Pharmaceuticals Inc3.41%2.28%
Amgen Inc3.18%1.82%
Gilead Sciences Inc2.89%2.82%

Source: SEC Form N-PORT

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between FTXH and PRHSX?
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both etfs. But PRHSX is far broader, holding 279 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.
Which is cheaper, FTXH or PRHSX?
FTXH has the lower expense ratio (0.6%).
Should I own both FTXH and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.